Concepedia

Rolando Pajón

RP

60

Publications

5.6K

Citations

31

H-Index

1997

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Duke Medical Center

Centro de Ingeniería Genética y Biotecnología

Brigham and Women's Hospital

Baylor College of Medicine

Rolando Pajón is an author at Moderna Therapeutics (United States) specializing in medicine, vaccination, and vaccine development.

ORCID

Top concepts

Publications per year

1997–2023

60

Publications

60

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott et al. · Science · 2022 · 1.2K citations · Full text

, , +9

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · New England Journal of Medicine · 2021 · 647 citations · Full text

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Angela Choi, Matthew Koch, Laurence Chu et al. · Nature Medicine · 2021 · 446 citations · Full text

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Xiaoying Shen, Haili Tang, Charlene McDanal et al. · Cell Host & Microbe · 2021 · 389 citations · Full text

, , +8

A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

Laurence Chu, Roderick McPhee, Wenmei Huang et al. · Vaccine · 2021 · 229 citations · Full text

Rows per page

1–5 of 60